All News

2020

September

Novartis development specialist working on a lab.
In The News / Sep 14, 2020

Proactive scenario planning and supply risk management

Steffen Lang, Global Head Novartis Technical Operations, on communication, data and automation during the COVID-19 crisis.

Read More
Media Release / Sep 14, 2020

European Medicines Agency (EMA) approves safety label update for Novartis Beovu®

Read More
Media Release / Sep 14, 2020

Novartis reports positive topline results from the first Phase III trial of Beovu® versus aflibercept in patients with diabetic macular edema (DME)

Read More
Media Release / Sep 11, 2020

Novartis data show early treatment with Mayzent® (siponimod) delays disability progression and show benefits in cognitive performance in patients with secondary progressive multiple sclerosis (SPMS)

Read More
Media Release / Sep 11, 2020

Novartis presents data at ACTRIMS-ECTRIMS for Kesimpta® (ofatumumab) in newly diagnosed treatment-naïve adults with relapsing multiple sclerosis

Read More
Nuclear Medicine
Story / Sep 11, 2020

Not your grandparents’ nuclear medicine

Novartis is taming nuclear power and putting it to use to treat advanced cancer.

Read More
Featured News / Sep 09, 2020

New report shows how AI in health is critical for COVID-19 response and recovery

AI offers the greatest potential to transform health systems from being reactive to proactive, predictive, and even preventive.

Read More
Media Release / Sep 08, 2020

Novartis data at ACTRIMS-ECTRIMS highlight the strength of leading multiple sclerosis (MS) portfolio with life-changing therapies for people across the MS spectrum

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More